Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: A specific combined long-chain polyunsaturated fatty acid supplementation reverses fatty acid profile alterations in a mouse model of chronic asthma

Fig. 1

Experimental design. C57BL/6 mice were sensitized with HDM (or PBS as control) for ten consecutive days (day (d)1-d10). After sensitization, mice received either no supplementation (PBS control and HDM group) or EPA or sc-LCPUFA supplementation (EPA and sc-LCPUFA group) for 24 days from d11 to d34. Furthermore, all mice received repetitive doses of HDM (or PBS) from d32 to d34 representing a realistic recall model. On d35, blood and lung tissue was collected and fatty acid profiles were determined by gas-chromatography. All four treatment groups (PBS, HDM, EPA and sc-LCPUFA) were statistically analyzed by using One-Way ANOVA with Dunnet’s post-hoc analysis against the disease group (HDM)

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X